HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M D Barber Selected Research

Neoplasms (Cancer)

8/2011The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study.
11/2004Interferon-gamma polymorphisms correlate with duration of survival in pancreatic cancer.
3/2004The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer.
10/2003Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
9/2001Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation.
1/2001The cancer cachexia syndrome.
1/2001Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
12/2000A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer.
9/2000Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients.
6/2000Disordered metabolic response with cancer and its management.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M D Barber Research Topics

Disease

12Neoplasms (Cancer)
08/2011 - 01/2000
12Pancreatic Neoplasms (Pancreatic Cancer)
11/2004 - 01/2000
8Cachexia
11/2004 - 06/2000
5Weight Loss (Weight Reduction)
10/2003 - 01/2000
2Breast Neoplasms (Breast Cancer)
08/2011 - 01/2004
2Stress Urinary Incontinence
01/2008 - 12/2000
2Pelvic Organ Prolapse
12/2000 - 12/2000
1Pain (Aches)
06/2014
1Urinary Incontinence
05/2014
1Fistula
05/2014
1Prolapse
03/2005
1Insulin Resistance
03/2004
1Iron Deficiencies
04/2002
1Acute-Phase Reaction
12/2000
1Glucose Intolerance
04/2000
1Weight Gain
04/2000
1Body Weight (Weight, Body)
01/2000

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
11/2004 - 06/2000
4Proteins (Proteins, Gene)FDA Link
03/2004 - 09/2000
4Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2000 - 01/2000
3Fish OilsIBA
09/2001 - 04/2000
3Eicosapentaenoic AcidIBA
01/2001 - 01/2000
2Glucose (Dextrose)FDA LinkGeneric
03/2004 - 04/2000
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
03/2004 - 10/2003
2Hormones (Hormone)IBA
01/2001 - 06/2000
1TOR Serine-Threonine KinasesIBA
08/2011
1EverolimusFDA Link
08/2011
1Estrogens (Estrogen)FDA Link
03/2005
1InterferonsIBA
11/2004
1Interferon-gamma (Interferon, gamma)IBA
11/2004
1Interleukin-6 (Interleukin 6)IBA
03/2004
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2004
1LeptinIBA
03/2004
1AntioxidantsIBA
10/2003
1GuaiacIBA
04/2002
1PorphyrinsIBA
04/2002
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
09/2001
1eicosapentaenoic acid diesterIBA
04/2001
1EmulsionsIBA
04/2001
1InterleukinsIBA
12/2000
1DNA (Deoxyribonucleic Acid)IBA
12/2000
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2000
1SuspensionsIBA
12/2000
1Fibrinogen (Factor I)FDA Link
09/2000
1Phenylalanine (L-Phenylalanine)FDA Link
09/2000
1Serum AlbuminIBA
09/2000
1AlbuminsIBA
09/2000
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2000
1EicosanoidsIBA
06/2000
1Insulin (Novolin)FDA Link
04/2000

Therapy/Procedure

3Nutritional Support (Artificial Feeding)
01/2001 - 04/2000
1Aftercare (After-Treatment)
06/2014
1Hysterectomy
05/2014
1Repeat Cesarean Section
05/2014
1Stents
05/2014
1Gynecologic Surgical Procedures (Gynecologic Surgery)
05/2014
1Vaginal Hysterectomy
05/2014
1Suburethral Slings (Tension-Free Vaginal Tape)
01/2008
1Therapeutics
01/2004
1Radiotherapy
04/2001
1Drug Therapy (Chemotherapy)
04/2001
1Electrodes (Electrode)
12/2000